Your browser doesn't support javascript.
loading
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.
Karikari, Thomas K; Benedet, Andréa L; Ashton, Nicholas J; Lantero Rodriguez, Juan; Snellman, Anniina; Suárez-Calvet, Marc; Saha-Chaudhuri, Paramita; Lussier, Firoza; Kvartsberg, Hlin; Rial, Alexis Moscoso; Pascoal, Tharick A; Andreasson, Ulf; Schöll, Michael; Weiner, Michael W; Rosa-Neto, Pedro; Trojanowski, John Q; Shaw, Leslie M; Blennow, Kaj; Zetterberg, Henrik.
  • Karikari TK; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Benedet AL; Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, H4H 1R3, Montreal, QC, Canada.
  • Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Lantero Rodriguez J; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Mölndal, Sweden.
  • Snellman A; King's College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
  • Suárez-Calvet M; NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK.
  • Saha-Chaudhuri P; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Lussier F; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Kvartsberg H; Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520, Turku, Finland.
  • Rial AM; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Pascoal TA; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Andreasson U; Servei de Neurologia, Hospital del Mar, Barcelona, Spain.
  • Schöll M; Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
  • Weiner MW; Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada.
  • Rosa-Neto P; Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, H4H 1R3, Montreal, QC, Canada.
  • Trojanowski JQ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Shaw LM; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Zetterberg H; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Mölndal, Sweden.
Mol Psychiatry ; 26(2): 429-442, 2021 02.
Article en En | MEDLINE | ID: mdl-33106600
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article